Prof. Gudrun Schleiermacher Joins NBA Advisory Board

Introducing Our New Scientific Advisory Board Member

We are exceptionally proud of our world-class Scientific Advisory Board, which plays a vital role in assessing funding for proposed research projects. We are thrilled to welcome Professor Gudrun Schleiermacher as the newest member of the Board.

Professor Gudrun Schleiermacher is a leading paediatric oncologist and researcher at Institut Curie in Paris, where she specialises in neuroblastoma and precision medicine for children with cancer.

As a physician-scientist, she combines patient care with cutting-edge research, leading international clinical trials and major European collaborations to improve treatments and outcomes for young patients. Her work has helped identify key genetic drivers of neuroblastoma and advance more personalised treatment approaches for children worldwide.

Professor Andy Pearson has been an integral member of our Board for several years, and we have greatly benefited from his deep expertise in childhood cancer. As he steps down from his role, we extend our sincere thanks for his invaluable contribution and dedicated service. We wish him all the very best in his future endeavours.

Find out more about our Board and its members here:

August 2026

On Sunday 9 August 2026, take on Australia's most iconic fun run and help make a difference for children with neuroblastoma. Starting in Sydney's CBD at Hyde Park and finishing at Bondi Beach, City2Surf is a 14km event that brings together thousands of runners, walkers and fundraisers each year.
National Childhood Cancer Roadmap Recognises CAR T-Cell Therapy as a National Priority

Neuroblastoma Australia has welcomed the release of the National Childhood, Adolescent and Young Adult Cancer Roadmap, describing it as an important step forward for children and families affected by cancer.
Neuroblastoma Australia Responds to Federal Budget Announcement

Neuroblastoma Australia is extremely disappointed the Federal Budget did not include specific funding for CAR-T Cell treatment for solid tumours - it’s a devastating omission for Australian children diagnosed with neuroblastoma.
Oaten's | Raising funds for research into neuroblastoma

I'm fundraising for Neuroblastoma Australia, to raise funds for vital research into better, kinder and more effective treatments for the children's cancer neuroblastoma. Please show your support by donating via this page.

What is neuroblastoma?
Donate today

One in two children with aggressive neuroblastoma will not survive. Neuroblastoma is the number one toddler cancer. We need your help to find effective treatments. Donate today to support world class Australian research into developing less toxic, more effective treatments, with the ultimate goal of finding a cure. Donate as an individual or business and receive a tax-deductible receipt for all donations over $2.
Detection, diagnosis & staging

Know about symptoms of neuroblastoma, detection, diagnosis and different stages of neuroblastoma childhood cancer.
How common is neuroblastoma?
How dangerous is neuroblastoma?
Our Story

Neuroblastoma takes the lives of more children under five than any other cancer. Help us fund new research to find a cure within our lifetime and save toddlers' lives.
How is it diagnosed?
Why does this cancer form?
Golf2Cure 2025

Our 2025 charity golf day, Golf2Cure, will take place on Thursday, June 26 at the prestigious Lakes Golf Club at Eastlakes, Sydney. The aim of the day is to have fun, increase awareness of neuroblastoma, and to raise funds for research into this devastating childhood cancer so we can find treatments that are more effective and less toxic.
Key Statistics

Know key statistics about the childhood cancer, neuroblastoma. Neuroblastoma is the most common solid tumour of childhood and its treatment. Most neuroblastomas, made up of cells found in nerve tissues of the body, start in the adrenal glands.